Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | LLY | ZBH |
|---|
| Close | 1,417.54 | 94.52 |
| Market Cap | $1.34T | $18.8B |
| 1M | +22.51% | +6.41% |
| P/E (TTM) | 50.2 | 22.3 |
| Forward P/E | 26.3 | 10.5 |
| P/E 5-Yr Percentile | 28 | 28 |
| P/S | 16.8 | 2.1 |
| P/B | 39.6 | 1.4 |
| Dividend Yield | 0.75% | 1.04% |
| Latest Quarter Revenue | $24.4B | $2.2B |
| Revenue YoY | +38.6% | +4.8% |
| Gross Margin | 83.9% | 70.8% |
| Latest Quarter EPS | 7.22 | 1.03 |
| Avg Post-Earnings Move | ±3.5% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 0.88% | 5.00% |
| 90-Day Net Insider Buying | −$16.0M | −$0.82M |
LLY · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
